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Urban Aedes mosquitoes are vectors of many viruses affecting human health such as dengue, 
chikungunya and Zika viruses. Insecticide resistance and environmental toxicity risks hamper the 
effectiveness of chemical control against these mosquito vectors. Alternative control methods, such 
as the use of mosquito‑specific entomopathogenic viruses should be explored. Numerous studies have 
focused on evaluating the potential of different densoviruses species as biological control agents. 
However, knowledge on the extent of inter‑ and intra‑specific variations in the susceptibility of Aedes 
mosquitoes to infection by different densoviruses remains insufficient. In this study, we compared 
infection and mortality rates induced by the Aedes albopictus densovirus 2 in different strains of 
Aedes albopictus and Aedes aegypti mosquitoes. The two Aedes species were different in terms of 
susceptibility to viral infection. Under laboratory conditions, Aedes albopictus densovirus 2 appeared 
more virulent for the different strains of Aedes aegypti tested than for those of Aedes albopictus. 
In addition, we also found significant intra‑specific variation in infection and mortality rates. Thus, 
although even if Aedes albopictus densoviruses could be powerful biocontrol agents used in the 
management of urban Aedes populations, our results also call into question the use of single viral 
isolate as biocontrol agents.
Aedes albopictus (the tiger mosquito) and Ae. aegypti (the yellow fever mosquito), are particularly invasive species 
that proliferate in tropical and temperate urban environments and are the main vectors of dengue, chikungunya, 
yellow fever and more recently Zika viruses. In the context of globalization and the movement of goods and 
people, these emerging vector-borne diseases are now present on almost every  continent1,2.
In the absence of vaccine or antiviral therapy for the majority of these diseases, vector control is the main 
strategy to prevent their spread. This is mainly practiced by controlling adult mosquito populations through 
spatial treatments, in emergency situation, using pyrethroid-based chemical insecticides and by controlling larvae 
through physical suppression of breeding sites or larvicides. The application of insecticides can be problematic 
because of their high environmental and human health  toxicity3–6, their general toxicity to non-target  insects7, 
and the insecticide resistance of target  mosquitoes8,9. Pyrethroids are the most widely used chemical insecticides 
in the world but their intensive use has led to the selection of pyrethroid resistant mosquitoes  worldwide8,10,11. 
Many innovative approaches are being developed to control Aedes sp. mosquitoes such as adult traps, lethal 
ovitraps, autodissemination stations, release of insects with dominant lethality (ridl), sterile insect technique, 
incompatible insect  technique12 but larval control remains essential and is systematically included in any inte-
grated control strategy.
The control of urban Aedes larvae is extremely complex to implement because of the diversity and multitude 
of larval habitats, which are made up of small, and usually cryptic, water  containers13. Apart from chemical 
larvicides (e.g. temephos, pyriproxyfen, diflubenzuron), the biological larvicide recommended against urban 
Aedes larvae is derived from Bacillus thuringiensis subsp. israelensis (Bti), a natural soil bacteria selected for its 
exclusive pathogenic action on some species of  Diptera14. However, its effectiveness is limited by many biologi-
cal and environmental factors: sunlight, amount of organic matter, larval density and depth of breeding  sites15. 
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For the moment, no resistance to Bti has been observed in mosquito but it is crucial to develop other candidate 
larvicides to fulfil the range of effective and environmental-friendly control tools. The use of several bio-larvicides 
with different action spectra should ensure effective, feasible and sustainable vector control and should contribute 
to manage the resistance of target insects to the active molecules.
Many viruses are known to be pathogenic for  mosquitoes16–18, but their potential use in biological control 
has been limited by their low infectivity or a production method unsuitable for field treatment. Mosquito denso-
viruses (MDVs), that exhibit a narrow host range and multiple transmission patterns, are, however, a potential 
 alternative19,20. Densoviruses (DVs), also known as densonucleosis viruses, are small icosahedral non-enveloped 
DNA viruses belonging to the Parvoviridae family and are highly infectious for invertebrate (insects, crustaceans 
and echinoderm)21,22. MDVs have been isolated from laboratory colonies or natural populations of mosquitoes 
and from chronically infected mosquitoes-derived cell lines. Within the Brevidensovirus genus, there are cur-
rently two type species with 9 virus species (i) the Dipteran brevidensovirus 1 with Aedes aegypti densovirus 1 
and 2  (AaeDV123 and  AaeDV224 respectively), Aedes albopictus densovirus 1  (AalDV125), Culex pipiens pallens 
densovirus  (CppDV26) and Anopheles gambiae densovirus  (AgDV27), (ii) the Dipteran brevidensovirus 2 with 
Aedes albopictus densovirus 2 and 3  (AalDV228 and  AalDV329 respectively) and Haemagogus equinus denso-
virus  (HeDV30). In the genus Ambidensovirus, only one strain has been described, the Culex pipiens densovirus 
 (CpDV31). Five others viruses are described in literature but are not yet included in the official taxonomy. Three 
strains of Aedes albopictus densoviruses,  AalDV432 to AalDV6 have been isolated and described from C6/36 cell 
line without any cytopathic effect suggesting that persistent cryptic infections are  common30. The sequences of 
these viruses are sufficiently different that it is highly unlikely that they have evolved from a single contamina-
tion  event30. Despite the lack of cytopathic effect in cell lines, theses MDVs have been shown to be pathogenic 
to mosquito larvae by oral infection and are able to replicate and to be transmitted in adult mosquitoes. Unlike 
strains isolated from cell lines, a new strain, AalDV7, was isolated from field-collected Ae. albopictus33. The 
Aedes Thai strain densovirus (AthDV) was detected in colonies of Ae. aegypti and Ae. albopictus from  Thailand34. 
MDVs can infect a wide range of mosquitoes, but natural infection appears to be confined to a single host species. 
The host range has been more or less well described according to the viruses. AaeDV1, the best characterized 
of them, was infectious in laboratory experiments for Ae. aegypti, Ae. albopictus, Ae. cantans, Ae. caspius, Ae. 
geniculatus, Ae. vexans, Cx. pipiens and Culiseta annulata19. MDVs are thought to persist in nature by horizontal 
transmission from larvae to larvae in the wild aquatic environments, although transovarial and sexual transmis-
sion have also been  recorded3,20,27,33–37. They are highly pathogenic for larvae at all stages, but mortality is higher 
when infection occurs at an early stage. Older larvae can survive and grow into imago after the virus infection, 
and infected adult female mosquitoes can transmit the virus vertically to the next  generation38. Mortality is 
also higher during critical phases of mosquito life, especially during larval metamorphosis, pupation and adult 
emergence, which require more energy.
MDVs are emerging as promising tools for the control of Aedes mosquito population. The objective of the ERC 
Revolinc project, that funded this study, is to use these biopesticides to boost the sterile insect  technique39. Sterile 
males would thus be coated with these viruses before being release, thus contaminating wild females even in the 
absence of successful  mating39. Most studies have been devoted to evaluating the potential of different MDVs 
strains as biocontrol agents. Knowledge on the extent of inter- and intra-specific variations in the susceptibil-
ity of Aedes mosquitoes to DVs infection are lacking. The overall objective of this study was to determine the 
potential of AalDV2 as a biological control agent against Aedes urban mosquitoes. AalDV2 (formerly known as 
AaPV for Aedes albopictus parvovirus) was isolated from a chronically infected cell line of the C6/36 clone of 
Ae. albopictus28,40,41 and was found to be highly pathogenic for Ae. aegypti neonate larvae reaching 95% mortal-
ity in the N’ Goye strain. No data are available on the pathogenicity of this virus to Ae. albopictus. In this work, 
we assessed the pathogenicity of AalDV2 against different strains of Ae. albopictus and Ae. aegypti mosquitoes 
from different geographical areas.
Results
Susceptibility of different strains of urban Aedes to AalDV2 infection. Three replicates of 150 
first-instar larvae of each strain of Ae. albopictus and Ae. aegypti were, or not, exposed to AalDV2. Larval mor-
tality appeared 5–7 days after infection for Ae. aegypti strains and 6–9 days after infection for Ae. albopictus 
strains. For all strains, peak of mortality occurred before adult emergence, between 6 and 10 days post infection 
(p.i.). Figure 1 shows the percentage of cumulative mortality on day 25 after infection, corresponding to dead 
larvae or pupae as well as individuals that disappeared uring the experiment, in the control (CTL) and infected 
(I) groups. In the control groups, the mortality rate was about 5% for Ae. albopictus strains and up to 20% for 
Ae. aegypti Long-Hoa Permethrin strain (LHP) at the end of the experiment. Infection with AalDV2 caused 
mortality in both species. However, under the same rearing and bioassay conditions, Ae. aegypti strains showed 
a higher cumulative mortality rate than Ae. albopictus strains (Table S1, p < 0.001) suggesting that AalDV2 is 
more pathogenic for this species.
Differences in intra-specific susceptibility to the virus were also observed. In Ae. aegypti, the cumulative mor-
tality of larvae and pupae infected with AalDV2 was up to 92% for the Bora Bora strain (BB), 86% for the LHP 
strain and 79% for the Benin strain (SBE). Mortality rates of controls without infection were similar (Table S2, 
p = 0.247) for BB and SBE strains, and higher than those observed for LHP (p < 0.001). Viral infection increased 
mortality of all strains (p < 0.001), but more for BB than for LHP and SBE (p < 0.001). In Ae. albopictus strains, 
we observed 55% mortality in AalDV2-infected mosquitoes for the Montpellier strain (MTP) and 19% for the La 
Réunion strain (LR). The impact of the virus on mortality was significant (Table S3, p < 0.001) and greater for the 
MTP strain than for the LR strain (p < 0.001). Mortality occurred at different stages of mosquito development. 
Larval mortality in Ae. aegypti was 73% for the LHP, 72% for the BB and 69% for the SBE strains; compared to 
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16% for the MTP and 6% for the LR strains of Ae. albopictus. Pupal mortality in Ae. albopictus was 38% for the 
MTP and 13% for the LR strains; compared to 13% for the LHP, 10% for the SBE and 20% for the BB strains 
of Ae. aegypti. Overall, there were significant differences in the pathogenicity of AalDV2 between the different 
strains of Aedes mosquitoes. Mortality was lower and occurred later for the tested strains of Ae. albopictus than 
for the Ae. aegypti strains.
Dead mosquitoes were collected daily and analysed by qPCR for detection and quantification. In the infected 
groups, the virus was detected in all dead mosquitoes both in the larval and pupal stages (100%, N = 1322). Con-
trol mosquito were negative for any densoviruses infection. Moreover, no virus detection was observed in the 
control mosquito samples that died during the experiment (N = 234). Figure 2 shows the viral dose quantified in 
dead larvae and pupae for each strain tested of Ae. albopictus and Ae. aegypti. Viral doses were slightly higher in 
Figure 1.  Percentage of cumulative mortality, corresponding to dead larvae or pupae, 25 days following 
AalDV2 infection of first instar mosquito larvae from different strains of Ae. albopictus (MTP, Montpellier and 
LR, La Réunion) and Ae. aegypti (LHP, Long-Hoà, BB, Bora-Bora and SBE, Benin). Larvae (N = 3 replicates of 
150 larvae per experimental condition) were infected, or not, with 3 × 1011 veg/ml of AalDV2. Binomial linear 
mixed effect models were used to compared the impact of AalDV2 in infected groups (I) compared to control 
groups (CTL). ***p-value < 0.001.
Figure 2.  Viral dose in dead larvae or pupae of AalDV2-infected mosquitoes for each tested strain of Ae. 
aegypti (LHP, Long-Hoà, BB, Bora-Bora and SBE, Benin) and Ae. albopictus (MTP, Montpellier and LR, La 
Réunion). Larvae (N = 3 replicates of 150 larvae per experimental condition) were infected, or not, with 3 × 1011 
veg/ml of AalDV2. Viral doses of dead larvae and dead pupae are expressed as log 10 of the number of AalDV2 
genomes quantified (gev) by qPCR in each individuals. Wilcoxon W test was used to compared virus titer in 
larvae compared to pupae for each strain. ***p-value < 0.001; *p-value < 0.05; n.s., not statistically significant.
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larvae than pupae, except for the LR strain of Ae. albopictus where pupae were significantly more infected than 
larvae (Wilcoxon test, W = 645, p < 0.0001).
Table 1 shows the mean viral copy number of the AalDV2 for each strain tested according to stage of devel-
opment. In Ae. aegypti larvae, viral titers reached 5.14E + 11 gev/individual in BB strain, 1.49E + 11 gev/indi-
vidual in LHP strain and 1.33E + 11 gev/individual in SBE strains with an average of 1.73E + 11 ± 6.72E + 10 gev/
individual for BB strain, 8.89E + 10 ± 4.51E + 10 gev/individual in LHP strain and 4.40E + 10 ± 8.51E + 09 gev/
individual in SBE strain. In larvae of Ae. albopictus, viral titers were less important and reached 6.81E + 10 gev/
individual in MTP strain and 1.12E + 09 gev/individual in LR strain with an average of 1.85E + 10 ± 5.7E + 09 
gev/individual in MTP strain and 1.20E + 08 ± 1.98E + 08 gev/individual in LR strain. In pupae, viral titer was on 
average significantly lower than in larvae, although we observed very high titer in some individuals, including in 
Ae. albopictus. Indeed, the viral titers reached 8.71E + 11 gev/individual in the BB strain, 3.80E + 11 gev/individual 
in the LHP strain, 1.26E + 11 gev/individual in the SBE strain, 1.27E + 11 gev/individual in the strain MTP and 
1.30E + 11 gev/individual in the LR strain. On average, we obtain 7.60E + 10 ± 8.76E + 10 gev in the BB strain, 
5.03E + 10 ± 4.15E + 10/individual in the LHP strain, 2.44E + 10 ± 9.98E + 09 gev/individual in the SBE strain of Ae. 
aegypti. In pupae of Ae. albopictus, viral titers were less important excepted for LR strain. We obtained an average 
of 9.83E + 09 ± 4.6E + 09 gev/individual in MTP strain and 1.35E + 10 ± 9.86E + 09 gev/individual in LR strain.
Impact of densovirus infection on the predation of infected larvae. At the end of the experiment, 
all individuals were counted. Missing individuals between the start (n = 150/replicate) and the end of the trial 
were considered as consumed by the others. Under these conditions of infection and rearing, Ae. albopictus 
strains are significantly less prone to predation after DVs infection than Ae. aegypti strains (Table S4, p < 0.001). 
As shown in Fig. 3, in the Ae. albopictus strains, we observed little losses with only 8.2% in the MTP strain 
(Table S6, p < 0.05) and 1.3% in the LR strain (p = 0.399). We frequently observed high losses in infected groups 
of Ae. aegypti. Missing larvae in AalDV2-infected mosquitoes reached 40.7% in the BB strain, 33.6% in the 
LHP strain and 38.5% in the SBE strain. Viral infection increased the loss of larvae in all strains of Ae. aegypti 
(Table S5, p < 0.001), but more so in the BB and SBE strains than in the LHP strain (p < 0.001).
Densovirus infection on surviving adults. Surviving emerged adults (males and females) were collected 
daily and analyzed by qPCR for AalDV2 detection and quantification. The infection rate in surviving adults was 
very high: the virus was still present after the emergence of adults at a significant level. As shown in Fig. 4 the 
prevalence of AalDV2 in surviving adults was higher in Ae. albopictus strains than in Ae. aegypti strains, with 
comparable prevalence rates between MPT (90.3%) and LR (85.7%). In Ae. aegypti, surviving adults of the SBE 
strain are significantly less infected than the two other strains (Table S7, p < 0.01). Thus, we observed that 62.6% 
(72 of 115) of surviving adults of the SBE strain, 67.6% (23 of 34) of the LHP strain, and 79.6% (43 of 54) of 
the BB strain of surviving adults were infected with AalDV2. The overall frequency of infection did not vary by 
gender. In Ae. albopictus, 87.9% of females and 92.7% of males for the MTP strain were infected with AalDV2 
compared to 82% of females and 92.7% of males for the LR strain. In Ae. aegypti, the prevalence rates of AalDV2 
infection were 60% of females and 78.6% of males for the LHP strain, 66.2% of females and 56.1% of males for 
the SBE strain, and 74.4% of females and 93.3% of males for the BB strain.
The viral dose in surviving infected adults was not significantly different between the different strains of 
Ae. albopictus and Ae. aegypti. In Ae. aegypti, viral titers reached 3.61E + 10 gev/individual for the BB strain, 
1.84E + 10 gev/individual for the LHP strain and 3.19E + 10 gev/individual for the SBE strains with an average of 
3.45E + 09 ± 2.04E + 09 gev/individual for the BB strain, 2.23E + 09 ± 2.17E + 09 gev/individual for the LHP strain 
and 2.02E + 09 ± 1.30E + 09 gev/individual for the SBE strain. Similarly, in Ae. albopictus, viral titers reached 
3.42E + 10 gev/individual for the MTP strain and 3.41E + 10 gev/individual for the LR strain with an average of 
3.12E + 09 ± 1.37E + 09 gev/individual for the MTP strain and 2.92E + 09 ± 1.21E + 09 gev/individual for the LR 
strain. The viral dose was not significantly different in surviving adults by gender.
The surviving emerged adults were sorted by sex. Table 2 shows the sex ratio between males and females by 
infection status and species. Imbalances in sex ratios were observed in the infected groups compared to control 
groups for SBE (p < 0.05) and BB (p < 0.001) strains of Ae. aegypti but not for LHP strain (p = 0.1). No differences 
were observed in Ae. albopictus MTP (p = 0.81) and LR (p = 0.83) strains.
Table 1.  Mean viral copy number of AalDV2 in dead larvae and pupae for each tested strain of Ae. aegypti 
(LHP, Long-Hoà, BB, Bora-Bora and SBE, Benin) and Ae. albopictus (MTP, Montpellier and LR, La Réunion). 
Larvae (N = 3 replicates of 150 larvae per experimental condition) were infected or not, with 3 × 1011 veg/ml of 
AalDV2. Viral doses of dead larvae and pupae are expressed as the number of AalDV2 genomes quantified by 
qPCR in each individuals (gev/individual). a Aedes aegypti; bAedes albopictus.
Virus titer in dead larvae (gev/individual) Virus titer in dead pupae (gev/individual)
BBa 1.73E + 11 ± 6.72E + 10 7.60E + 10 ± 8.76E + 10
LHPa 8.89E + 10 ± 4.51E + 10 5.03E + 10 ± 4.15E + 10
SBEa 4.40E + 10 ± 8.51E + 09 2.44E + 10 ± 9.98E + 09
MTPb 1.85E + 10 ± 5.87E + 09 9.83E + 09 ± 4.60E + 09
LRb 1.20E + 08 ± 1.98E + 08 1.35E + 10 ± 9.86E + 09
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Discussion
Originally established from homogenates of mosquito  larvae42, Ae. albopictus C6/36 cells are highly permissive 
to many  arboviruses43 and are widely used for screening mosquito field collections. Aedes albopictus Densovirus 
2, AalDV2, was first described in a C6/36 cell sub-line during a study on arboviruses in African  mosquitoes28. Its 
origin is unknown but is probably due to contamination by samples of infected mosquito collected in the field. 
Our results showed that not only Ae. aegypti but also, for the first time, Ae. albopictus, were both susceptible to 
oral infection with AalDV2. However, we showed intra-specific and inter-specific variation in infection between 
the five different strains of mosquitoes tested, including insecticide resistant strains. The Long-Hoà (LHP, Viet-
nam) strain of Ae. aegypti and the La Réunion (LR) strain of Ae. albopictus are both pyrethroid-resistant strains. 
We have shown that these two strains are as susceptible to viral infection as the other strains. Most notably, 
Figure 3.  Larval cannibalism rate on day 25 after AalDV2 infection of first instar mosquito larvae for the 
different strains tested of Ae. albopictus (MTP, Montpellier and LR, La Réunion) and Ae. aegypti (LHP, Long-
Hoà, BB, Bora-Bora and SBE, Benin). Larvae (N = 3 replicates of 150 larvae per experimental condition) were 
infected or not, with 3 × 1011 veg/ml of AalDV2. Binomial linear mixed effect models were used to compared the 
impact of AalDV2 on cannibalism in infected groups (I) compared control groups (CTL). ***p-value < 0.001; 
**p-value < 0.01; n.s., not statistically significant.
Figure 4.  Percentage of infected adults surviving after AalDV2 infection of first instar mosquito larvae for the 
different strains tested of Ae. albopictus (MTP, Montpellier and LR, La Réunion) and Ae. aegypti (LHP, Long-
Hoà, BB, Bora-Bora and SBE, Benin). Larvae (N = 3 replicates of 150 larvae per experimental condition) were 
infected or not, with 3 × 1011 veg/ml of AalDV2. Binomial linear mixed effect models were used to compared the 
impact of AalDV2 in different strains. **p-value < 0.01; n.s., not statistically significant.
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AalDV2 appeared to be more pathogenic for Ae. aegypti than for Ae. albopictus. Mortality was mainly observed 
at larval stage in Ae. aegypti strains, compared to Ae. albopictus strains where less than 20% of larvae died before 
pupation. Viral titers of dead individuals were higher in larvae than in pupae and in Ae. aegypti strains than in 
Ae. albopictus strains. This suggests that clearance of the virus could occur between each larvae moult and be 
released into the rearing water during the moulting process. The virus appeared to replicate less in Ae. albopictus 
strains, which could explain its lower impact on this species. AalDV2 was isolated from persistently infected 
cell lines derived from Ae. albopictus which may have reduced the virulence of the densovirus strain to this spe-
cies. Studies using C6/36 densoviruses on Ae. albopictus are poorly documented. A single study on AalDV1 has 
shown that this isolate seems to be very pathogenic for the Guangdong Ae. albopictus strain (China)38. However, 
the mortality observed since one day post-infection is questionable and may not be linked to the virus, but to 
environmental factors or to rearing conditions.
We also observed a variation in susceptibility to infection at the intra-specific level. Indeed, for Ae. aegypti, 
the Bora Bora strain (BB) had a statistically higher mortality rate after exposure to AalDV2 compared to the 
two others strains, Long-Hoà (LHP) and Benin (SBE). This difference in intra-specific susceptibility could be 
a consequence of the lower genetic variability of the BB strain associated with its older establishment in the 
insectarium compared to the two others strains. Similarly, for Ae. albopictus, the Montpellier strain (MTP) had 
a much higher mortality than the La Réunion strain (LR). The dynamics of infectious diseases can be affected 
by genetic diversity within host  populations44 as well as by the time of colonization of laboratory populations of 
Aedes  mosquitoes45. Previous studies using MDVs have shown a high level of mortality for the same species of 
mosquito exposed to different isolates of DVs, with some isolates being highly pathogenic, others more benign. 
For example, as they are different viral strains, AalDV1 infection resulted in a mortality rate of over 90% in 1st 
instar A. aegypti  larvae28, while AaeDV infection results in a mortality of 75.1% for the same  species46. Thus, 
after infection with AthDV, first-instar larvae of the Thai strain of Ae. albopictus, had a mortality of 82% com-
pared to 51% for Ae. aegypti34. Different DVs strains such as AaeDV1, AthDV, AalDV2 and AalDV3 induced 
completely different levels of mortality when infecting Rexville D, Chachoengsao, and Bangkok strains of Ae. 
aegypti after 48 h exposure to DVs at 2 × 1010 gev/larvae47. Recently, analysis of sublethal effects also showed 
that AalDV7 infection of Ae. aegypti and Ae. albopictus first instar larvae significantly decreased pupation and 
emergence  rates33. However, the diversity of experimental designs used does not allow easy comparison of the 
results across studies, due to differences in infection methods, environmental conditions, viral titers, and stage 
of larvae infected. Some intrinsic factors such as their genetic background, or their microbiota, could influence 
the susceptibility of mosquitoes to DVs infection but these mechanisms need to be explored. For example, in 
Bombyx mori lepidoptera, resistance to Bombyx mori densovirus type 1 or 2 (BmDV1 & BmDV2) is controlled by 
recessive non-susceptibility genes, nsd-1 and -248,49, which affect distinct stages of the viral infection  pathway50. 
In addition, a recent study has shown that Wolbachia pipientis infection promotes the replication of the Aedes 
albopictus densovirus 1 (AalDV1) in Aedes cell lines in a density dependent  manner51. Further studies are needed 
to determine how these laboratory results may result in increased susceptibility to DVs in natural populations of 
Wolbachia-infected Ae. albopictus or artificially Wolbachia-infected Ae aegypti. Furthermore, the pathogenicity, 
prevalence and infection rate of MDVs may also vary with on environmental factors such as temperature, or other 
conditions such as larval density, method of infection and duration of exposure to  MDVs40,52. The environmental 
factors that influence the efficacy of MDVs have not been thoroughly studied and further research is needed 
before these MDVs can be eligible for operational use in mosquito control programs.
Table 2.  Sex ratio (female number/male number) in control and infected groups for each strains of Ae. aegypti 
(LHP, SBE, BB) and Ae. albopictus (MTP, LR) (*p < 0.05; ***p < 0.001; Chi-squared test). a Aedes aegypti; bAedes 
albopictus.
Female Male sex-ratio F/M χ2, df = 1, p value
LHPa
Control 117 141 0.83
2.65, p = 0.10
Infected 21 14 1.5
SBEa
Control 135 134 1.01
5.30, *p < 0.05
Infected 73 43 1.70
BBa
Control 111 138 0.80
13.98, ***p < 0.001
Infected 38 14 2.71
MTPb
Control 111 115 0.97
0.05, p = 0.81
Infected 32 31 1.03
LRb
Control 154 144 1.07
0.04, p = 0.83
Infected 128 124 1.03
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In mosquitoes, cannibalism between larval instars of the same species has been frequently observed, especially 
in the later instars, with food deficiency or excessively high larval densities applied under rearing  conditions53. 
Cannibalism is also an effective route of transmission for some pathogens, including DVs, when healthy larvae 
consume moribund infected ones. Sick larvae become lethargic in the later stages of infection and are unable 
to defend themselves against aggressive  conspecifics54. Under our laboratory conditions, Ae. albopictus and Ae. 
aegypti had a larval development cycle of 9–10 days at 26 °C from egg-laying to emergence. During our experi-
ment, infected larvae of Ae. aegypti showed a delay in development compared to unexposed larvae and especially 
compared to infected larvae of Ae. albopictus. After infection in the first-instar stage, larval development of 
infected Ae. aegypti larvae was heterogeneous compared to healthy larvae which have a more synchronized life 
cycle. Most of the cadavers collected were third and fourth instar larvae, while first or second instar larvae were 
rarely found. As larval mortality was checked and dead larvae were removed daily, we hypothesise that dead or 
dying larvae (infected with densovirus) were consumed by uninfected or less infected larvae through cannibalism 
(i.e. active killing and consumption of conspecifics) or necrophagy (i.e. consumption of dead conspecifics). The 
high incidence of larval predation observed in Ae. aegypti mosquitoes, a species more susceptible to AalDV2, 
suggests that this is an important pathway for the transmission and pathogenicity of this MDVs.
Adult mortality has not been evaluated in this work, but many studies have shown that DVs infection of 
mosquito larvae affects the life traits of infected  adults33,34,37. Thus, the effects of sublethal infection of Ae. aegypti 
larvae by different isolates of DVs included extended larval development times, reduced pupal and adults weight, 
decreased fertility of females, and decreased adult lifespan. Although the ability to modify adult life character-
istics, in particular fertility, differs between MDVs strains and mosquito species, a reduction in reproductive 
success could potentially lead to a decrease in mosquito density and vector capacity.
Females infected in the larval stage can transmit DVs vertically by laying infected eggs in new oviposition 
sites, resulting in the spread of MDVs in the mosquito population and an increased coverage and  efficacy55. A 
semi-field trial have shown that adult female Ae. aegypti oviposition behavior led to successful AaeDV dispersal 
from treated breeding sites to new breeding sites in large-scale cages. However, the AaeDV titers achieved in 
the contaminated sites were not sufficient to reduce larval  densities36. Further research is needed to assess for 
other MDVs whether this vertical transmission translates into operational efficiency in the field, which would be 
possible after one or more amplification cycles, as suggested by  Carlson19. Analysis of infection rates and titers 
in live adults revealed that virus replication occurred in all strains for both Aedes species tested. Most surviving 
adults were positive to AalDV2 detection after infection of first instar larvae. Infection rates in surviving adult 
of Ae. albopictus was higher than that of Ae. aegypti reaching 90%. Virus replication occurred in all strains for 
both mosquito species tested with an average viral titre of 6.5–11 log/after potential exposure of first larval stage 
to 10 log of virus. Among the few emerging adults, the viral titer of AalDV2 infected females and males did not 
vary significantly. However, in some mosquito’s strains, we observed a distortion of the sex-ratio in favour of 
females. Butchasky et al. also observed a mortality rate in adult males infected at the larval stage with DVs three 
times higher than that  females56. This selection could be of interest for spreading and maintaining the virus by 
vertical transmission from female to the offspring.
The results of this laboratory study provide baseline data on the susceptibility of Ae. albopictus and Ae. aegypti 
to AalDV2 infection. We have shown that the different strains of mosquitoes were susceptible to AalDV2 infec-
tion including for insecticides resistance strains. These results confirm even more the advantage of the isolate 
AalDV2 and of the DVs in general as a biological control agent. The differences in the pathogenicity of AalDV2 
among Aedes mosquito strains draw attention to the risk associated with the development of single viral strain 
for use as biocontrol agents. Our work also suggest that DVs strains isolated from heterologous mosquito species 
may be more efficient against a given species, probably because they are less well adapted. In addition, highly 
pathogenic DVs that kill larvae before they reach adulthood may exert high selective pressure, which would 
increase the risk of resistance and decrease their efficacy over time. Thus, AalDV2 could be a potential mosquito 
control agent, but further research and development work is still needed, including studies on the different routes 
of transmission and its persistence in the environment through semi-field evaluations. The continued discovery 
and isolation of new MDVs will enrich the pool entomopathogenic mosquito viruses and provide a variety of 
choices for one or more combinations of MDVs to optimally target Aedes mosquitoes. The ability to produce 
the virus on a large-scale at low cost and in sufficient quantities is also required before innovative formulations 
can be developed for operational use with other methods as part of integrated vector management. The develop-
ment of innovative formulations suitable for (i) direct use in breeding site or (ii) dissemination by the insects 
themselves according to the entomovectoring principle developed by the boosted SIT approach, is  underway39.
The main limitation of this study is the number of strains used. We focused our study on the infectivity of a 
mosquito densovirus, AalDV2, on five different strains of Aedes albopictus and Ae. aegypti. Other densoviruses 
strains and other mosquito strains could be used to support our results.
Methods
Virus and cells line. We used two Ae. albopictus derived C6/36 cell  lines42. The first, a chronically infected 
sub-line, was used as the source of the Aedes albopictus densovirus 2 (AalDV2)28. A second, free of any DVs, was 
used as a control. Both sub-lines were grown at 28 °C in RPMI medium (Dutcher, France), supplemented with 
10% heat-inactived fetal calf serum (Gibco, USA), 1% non-essential amino-acids (Gibco, USA) and 1% penicil-
lin–streptomycin (Gibco, USA). Cells were seeded at 7-days intervals in 25 cm2 flasks at 1:5 dilution. Infected 
cells were scraped into supernatant and kept at − 20 °C as virus stock. The viral concentration was estimated as 
described below. The titer, expressed as genome equivalent virus (gev), remained stable at 3 × 1011 gev/ml.
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Mosquito strains. Three different colonized strains of Ae. aegypti and two of Ae. albopictus have been used 
to study the pathogenicity of AalDV2 (Table 3).
The reference strain of Ae. aegypti BB (Bora-Bora, French polynesia) and SBE (Benin) have been colonized for 
many years and were devoid of any phenotypic resistance to World Health Organization (WHO) susceptibility 
tests at diagnostic doses for the most common chemical insecticides or any known mechanism of insecticide 
resistance. The LHP (Long-Hoà, Vietnam), pyrethroid-resistant strain of Ae. aegypti, is homozygous for the 
knockdown resistance (kdr)  gene57. In addition, we used two recently colonized Ae. albopictus strains from 
France. The La Réunion strain (LR), is a pyrethroid-resistant strain colonized since 2010 but whose resistance 
mechanism is currently under investigation. The Montpellier strain (MTP) susceptible to all insecticides has 
been colonized since 2016. Adult colonies are maintained in the Vectopole insectarium of IRD in Montpellier, 
France, at 28 °C, 70% humidity with a 14 h/10 h light/dark cycle and fed with 10% sugar solution. Female adult 
mosquitoes were artificially fed through a Parafilm-membrane (Hemotek membrane feeding systems, UK) using 
fresh rabbit blood kindly provided by IRD animal facilities. The larvae were reared at 28 °C in 2 l jars and fed 
with alevin powder. At 28 °C, pupae were obtained 6–7 days after immersion of the eggs in water and imago 
2 days later.
Virus infection of mosquito larvae from Ae. aegypti and Ae. albopictus. Newly hatched first instar 
Aedes larvae were infected as follow. Mosquito eggs were allowed to hatch in tap water with a 7.5% solution of 
50:50 alevin powder and rabbit pellets. Twenty-four hours after hatching, pools of 150 larvae were exposed 
to 3 × 1011 gev/ml of cells infected with AalDV2, theoretically corresponding to  1010 gev per larvae, in a total 
volume of 5 ml and kept without food for 48 h. The control groups, were exposed to healthy C6/36 cells under 
identical conditions to those of the treatment groups. Two days after infection, larvae were transferred to 300 ml 
water bowls with food and observed daily until pupation. Pupae were transferred to new small cups of clear 
water and allowed to emerge into mosquito cages. Dead larvae or pupae, were collected daily and stored at 
− 20 °C for further investigations. The emerged adults were collected daily and sorted by sex. The larval, pupal 
and cumulative mortality was evaluated at the end of bioassays at day 25 after infection. The adult mortality was 
not assessed. Three biological replicates of each strain were performed.
The cumulative mortality observed at the end of the experiment takes into account the number of dead larvae 
and pupae, plus larvae lost during the experiment due to predation.
Virus detection and quantification in mosquitoes. Quantification of the virus by qPCR was per-
formed using the LightCycler 480 System (Roche, France) and specific primers designed in the non-structural 
gene NS1 (qAalDV2-F: 5′-TggCCA ACA ATTACgAACAA-3′ and qAalDV2-R: 5′-CTCTggAgCCgCTgTg-
TAAT-3′). A standard curve  (109 to  103 viral genome copies per reaction) was generated using tenfold serial 
dilutions of pAalDV2, a plasmid encompassing the entire AalDV2  sequence58. The reactions were carried out 
in a 10 μl reaction mixture containing 5 µl of 1 × SyberGreen master mix I, 1.7 µl of DNase/RNase-free water, 
0.4 µM of each primers and 2.5 µl of sample. Each sample was processed in triplicate under the following condi-
tions: 95 °C for 3′, 45 cycles of 94 °C for 10 s, 60 °C for 10 s and 72 °C for 10 s. The data were analyzed using Light 
Cycler 480 software (Roche, France). Virus concentration in mosquitoes was determined individually and titers 
were expressed as genome equivalent virus (gev) per individual. Each individual (larvae, pupae or adult) was 
crushed in 50 µl of 0.1 × Tris–EDTA buffer supplemented with 0.05 µM salmon sperm DNA and the suspension 
was clarified for 5 min at 5000g before quantification.
Statistical analysis. Binomial linear mixed effect models were used to analyse the impact of AalDV2 infec-
tion on survival at intra- and inter-specific level, cannibalism and infection rates in surviving adults (response 
variables). The mosquito species and strain as well as the infection status were used as fixed effects and the repeti-
tions as random effects. Fixed-effects coefficients of all models and their corresponding p-values are reported in 
Tables S1 to S7. Data from viral concentration in dead or surviving individuals were analysed with Wilcoxon W 
test. Data from sex-ratio bias were analysed with chi-square test. By convention, results were considered statisti-
cally significant when p < 0.05.
Table 3.  Aedes albopictus and Ae. aegypti mosquitoes strains. BB Bora Bora, SBE Bénin, LHP Long-Hoà, 
MTP Montpellier, LR La Réunion. a Susceptible to all insecticides class. b Resistant to pyrethroids, the main 
insecticide class used for Aedes vector control, kdr: knockdown resistance. c The characterization of molecular 
and metabolic mechanisms of insecticide resistance is underway.
Species Strains Origin Lab colonization Status
Ae. aegypti
BB French Polynesia 1980 Susceptiblea
SBE Benin 2008 Susceptiblea
LHP Vietnam 1997 Resistantb (kdr)
Ae. albopictus
MTP France 2016 Susceptiblea
LR Overseas France 2016 Resistantb,c
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Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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